chrisvoncsefalvay/vaers-outcomes huggingface dataset:
During initial 24 hours after vaccine, had a very sore leg and fever around 100 F which was similar to her first PCV-13 shot two months prior.  Beginning around 24 hours after the vaccine, fever greater than 102 F.  Fever has lasted four days and still continuing as of this report.  In addition, lots of secretions in airway that are being coughed out of her trach.  Fever controlled with ibuprofen every 6 hours but has also required additional Tylenol a couple of times.
Pt had a grand mal seizure  at a restaurant witnessed by friends and staff . Collapsed on table and after shaking  of entire body was over, was unconscious for 15 minutes. Ambulance came and transported him. Ct done and labs were negative. Discharged and followed up with neurologist. Pt never had a seizure prior to this episode. Put on anti seizure meds and followed up with eeg and mri. Pt unable to drive for 6 months due to law . Patient hasn?t had another seizure since.
Patient reported that she has soreness and redness on the injection site.  When I called the patient today 05/23/2022. I ask her about the sign and symptoms, Patient stated the soreness and redness got bigger no difficulty of breathing, no dizziness or weakness, no fever. She put a triamcinolone acetonide 0.1% on the affected site and took Bendaryl and to no relief of redness according to the patient. I advised the patient to put Ice pack every 10-15 minutes and If she starts feeling  or having difficulty breathing, dizziness, weakness and rapid breathing , she should go to the Emergency room for further evaluation.
This spontaneous report as received from a physician assistant refers to himself, a 49 year old male patient. Information regarding relevant medical history and concurrent condition were not reported. On 08-MAR-2016 the patient was vaccinated with GARDASIL 9 (dose 1, lot #, route and dose not reported. Receiving GARDASIL 9 at 49 year old was considered as inappropriate schedule of vaccine administered. No adverse effects reported. Additional information has been requested.
4 days after flu vaccine noted on underside of left arm a painless rash, raised, blistered but now crusty burning eyes- red & draining- client telephone call to doctor- prescibed Clarinex 1 every day has been taking for several days with no relief- public health nurse referred back to doctor- will call today for appointment. Public health nurse telephone call 11/12/03 client saw doctor cortisone shot and "pills". No current problems.
Pt recvd 3rd DPT/OPV & 1st HIB, /Win 2 hrs became pale & limp-semi responsive 1/2 hr later noted to be cyanotic & lethargic, responded to stimulation /win several mins. Then returned to normal self except for T 101.9
numbness to her lower lip and half of her tongue.; numbness to her lower lip and half of her tongue.; This is a spontaneous report from a contactable consumer (patient herself). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration in left arm on 09Feb2021(at 65-years-old) as single dose for COVID-19 immunization. The patient's medical history included monoclonal B-cell lymphocytosis and ongoing hypertension has had for a couple of years. The concomitant medication included prednisone from 05Feb2021 to 09Feb2021 as taper dose for swelling, she was prescribed it for swelling due to a reaction from tape that was on her face after having cosmetic surgery and ongoing hydrochlorothiazide 2.5mg daily from an unspecified date in 2018 as diuretic. Patient did not take any medications within four weeks, Prior to vaccination. On 09Feb2021, a half an hour later she had numbness to her lower lip and half of her tongue. Patient can move her mouth fine, but the numbness was persisting. It feels more like a nerve issue. There were no additional vaccines administered on same date of the suspect and patient did not visited the emergency room or physician office. Patient was unsure about Lot number whether it was EL9269, E19269 or EI9269.The outcome of the event was unknown.
Interchange of vaccine products; COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Mar2021 as dose 1, single (Lot number: EP6955), on 13Apr2021 as dose 2, single (Lot number: ER8134) and on 10Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 57 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 29Apr2022 as dose 4 (booster), single (Lot number: 005MUA) and on 02Sep2022 at 12:00 as dose 5 (booster), single (Lot number: AS714DC), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "Known allergies:Amoxicillin", notes: Known allergies:Amoxicillin; Lamictal, reaction(s): "Known allergies:lamictal", notes: Known allergies: Lamictal. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Started Paxlovid one day after symptoms began and positive Covid test- day 1; Negative, notes: Days 8 Tested negative; Positive, notes: Day 12 tested positive For Covid again; Positive, notes: Day 16 tested again, still Positive/ That brings me through today. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient was generally quite healthy and fit. Patient received Treatment from18Nov2022 to 22Nov2022. It was unknown if the patient received any other medication in two weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a Licensed Practical Nurse refers to patients of unknown demographics. On an unknown date, an unspecified number of patients received improperly stored GARDASIL (dose details, lot number unspecified). No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This case is also related to 1507USA007760, 1507USA001935 and 1507USA007759 (same reporter link). Additional information has been requested.
Patient was administered first dose of covid vaccine today at 1500 patient stated to the operation scribe that her throat was feeling a little scratchy. Agency notified nurse RN. The nurse evaluated noted patient stated she was having trouble swallowing and felt like she was going to throw up. Nurse, RN administered 1-25mg tablet of Benadryl at 1510. Patient stated no relief and symptoms continued without any relief EMS was notified to evaluate patient. Patient opted to go to the ER via EMS for evaluation. Patient was loaded up into ambulance and was in stable condition. Patients husband stated he was following patient to the hospital with her belongings.
4 month old infant received first DTP/OPV immun. & had no immediate problems, was apparently well & healthy. 9-10 days later, developed repiratory symptoms & diarrhea, then found dead the following day.
Pt requested Hepatitis A and Hepatitis B vaccine. I checked NCIR to determine what was needed but overlooked that he already had his Hep B vaccine and gave TWINRIX vaccine. Hepatitis A - HAVRIX was the vaccine that should have been given.
tingling in the arm; Pain/ hurt a lot; Can't move arm; Panicking as never got pain like this; Chills; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Panicking as never got pain like this) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 126L20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 21-Jan-2021 at 5:55 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ANXIETY (Panicking as never got pain like this). At the time of the report, ANXIETY (Panicking as never got pain like this) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Heaviness and pain in shoulder area. Limited range of motion and pain in shoulder which has increased over the last 2 weeks. Patient reports that injection seemed higher than normal.
Urinary Tract Infection.  Completed course of  Cephalexin for 4 days, which almost cleared it up but not completely.  Eventually it went away on its own.  No previous history of UTI
Pain seems to be in shoulder area and bicep area; aching/ stabbing pain; Bump reappeared with red itchy rash; Extreme pain and mobility issues with left arm that lasted from time I received vaccine but  really worsened on 4/2/21./ Could not even lift my arm any distance from body in any direction; mobility issues/ did not had full mobility; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient (not pregnant) received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 30Mar2021 at 12:30 (Lot Number: EN6208) at the age of 60-year-old as single dose for COVID-19 immunization. Medical history included allergies to medications and food. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included estradiol, antihistamines, vitamins and progesterone. The patient experienced extreme pain and mobility issues with left arm that lasted from time received vaccine but really worsened on 02Apr2021. On 04Apr2021, the patient went to urgent care. Went again to primary care doctor 4/8/21. It was gotten better each day but still did not had full mobility and had some pain. The patient could not event lift arm any distance from body in any direction. Extreme pain on scale of 1-10, a definite 10. Aching, stabbing pain. Bump reappeared with red itchy rash on the 07Apr2021, but was not severe. And improved today the 10Apr2021. Still not able to fully extend arm up above head. Pain seems to be in shoulder area and bicep area. At 2nd application, they prescribed Prednisone as treatment for events. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Experiencing a very sore arm and it is hard to lift it and it is just sore, real sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) (patient's wife).  A 73 year-old male patient received bnt162b2 (BNT162B2), administration date 02Mar2021 11:10 (Batch/Lot number: unknown) at the age of 73 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for covid-19 immunization, reaction(s): "No problems". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 03Mar2021, outcome "unknown", described as "Experiencing a very sore arm and it is hard to lift it and it is just sore, real sore". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity.  Additional information: The patient had the first COVID shot and was fine. And received the second COVID shot and experiencing Sore arm, can hardly raise arm and it hurts and it is sore. Got vaccine on 02Mar2021 and yesterday (03Mar2021) woke with the sore arm and also this morning (04Mar2021) with a sore arm. The patient got the vaccine at (hospital name). The reporter wanted to know if it is a natural affect of the shot, the vaccine or not. No Investigation Assessment  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Pt recvd Hep B vax & exp n,v,d, & flu-like sx;
Eye twitching; This is a spontaneous report from a contactable Other HCP (patient). This 29-year-old female patient (no pregnant) received 1st dose of BNT162B2 Intramuscular on 07Jan2021 02:00 PM at single dose on Right arm for covid-19 immunization. Medical history was COVID prior vaccination. No other vaccine in four weeks. Concomitant drug was not reported. Patient experienced Eye twitching on 07Jan2021 04:00 PM. No treatment. Outcome of the event was Not Recovered. No COVID tested post vaccination.  No follow-up attempts are possible; information about batch number cannot be obtained.
Information has been received from a 75 year old female patient with diabetes mellitus, high blood pressure, "thyroid", penicillin and sulfonamide allergies who "3 years ago" in July 2007 was vaccinated SC with a dose of ZOSTAVAX (Merck) (Lot# unknown). Concomitant therapy included metformin hydrochloride (+) sitagliptin phosphate (MSD) and SYNTHROID. The patient stated that "about a month ago" in approximately June 2010, she experienced a "bad case of shingles", in which she was sick for two weeks prior to break out. The patient also stated, that she experienced a bad back ache, blisters, scabs, skin discoloration and a stabbing pain that feels like your skin was on fire and your did not want to touch it. There were no laboratory tests or diagnostic studies performed. At the time of the reported, the patient was recovering. The patient sought unspecified medical attention. Follow up information has been received from a completed questionnaire. A physician indicated that on 27-DEC-2007 the patient with no illness at the time of vaccination and a history of chickenpox at childhood was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# 658863/1414U) in his left arm. Rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. The physician stated that there was no adverse effect of vaccine. There was no recent exposure to chickenpox or Herpes zoster. The vaccine was not effective and on 23-JUL-2010 the patient developed herpes zoster, a fairly severe case with postherpetic neuralgia which lasted four months; the patient recovered from Herpes zoster. Distribution of dermatomes involved was T8 and T9 at 25 lesions. Pain was described as 8 in a scale from 0 to 10. The patient's maximum temperature was 98.4. There were no other systemic symptoms. Additional information is not expected.
Pump on right arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Pump on right arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Pump on right arm). At the time of the report, PERIPHERAL SWELLING (Pump on right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
patient did not experience any other AE; patient received after it experienced a temperature excursion; This spontaneous report was received from a medical assistant, and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 16-NOV-2021, the patient was vaccinated with one dose of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), lot number T037648, expiration date: 20-JUL-2023, administered as prophylaxis (strength, exact dose and route of administration were not provided). That vaccine dose had experienced a temperature excursion (product storage error), at 8.5 degrees Celsius (C) for 30 minutes, no previous temperature excursions were reported. No other adverse events were reported. The outcome of the event was unknown.   This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2112USA008421:02080041 US-009507513-2112USA008430:02080039
By 1:00am the patient's blister was better. By 9:00pm the following evening it was gone.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 15:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and herpes labialis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 01:00 the patient woke up on the morning of the vaccine with a herpes simplex on her lip. Normally her blisters swell and quadruple quickly. The patient applied the usual docosanol (ABREVA) and got the vaccine. By 01:00 the blister was better. By 21:00 the following evening it was gone. This is extremely unusual as it normally takes over 14 days for the blister to heal. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was recovered on 04Mar2021 at 21:00.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
shingles reoccurred.  I had shingles in 2008 and the shingrix vaccines 9/2020 and 11/2020
Patient experiencing visible rash on cheecks/face, and down chest. No SOB or distress. Able to swallow water.  Hr 77 O2 94 BP 133/105 Liquid Benadryl 50 mg 20 ml administered 11:37, patient had improvement. Offered medical transport. Patient declined due to improvement. Patient departed at 12:00 pm. Pt in passenger seat, mother driving. Instructed to go for further evaluation if symptoms reappear/worsen.
pt recvd vax for prophylaxis;24 hrs p/wards exp musculoskeletal pain in neck & upper torso; resolving;
Redness, itching, pain from injection site to elbow. KEFLEX 500 mg x 5 days.
Patient received a third dose of Pfizer Covid-19 vaccine before scheduled date. Dose 1: 15 JULY 2021 Dose 2: 10 AUG 2021
Pt devel red, raised rash at inject site. Reporter indicates that approx 25-30 of the 45 employees that received vax, devel a rash at the inject site. Additional reports to be generated.
A few days after taking the shot, I had headaches, ear ringing, and heavy head pressure. The ear ringing has persisted and I am still dealing with it. The doctor advised me to take Mucinex. Then I visited a new PCP to take a CT scan.
ONLY FELT SLIGHT EFFECTS THE  SECOND DAY AT NIGHT; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced only felt slight effects the second day at night. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of only felt slight effects the second day at night was not reported. This report was non-serious.
After receiving the COVID0-19 vaccine, client verbalized facial tingling.  Client was evaluated by onsite paramedics and released at 4:56 pm to go home
2 patients who were administered post temperature excursion with no reported adverse event; twenty minute excursion of 0.8C with no reported adverse event; Initial information received on 31-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves patients of unknown age and gender and it was reported twenty minute excursion of 0.8c and 2 patients who were administered poliomyelitis vaccine (inactivated) [IPOL] post temperature excursion with no reported adverse event.  On 01-Mar-2023, poliomyelitis vaccine (inactivated) suspension for injection (batch/lot number: V1B891M; expiry date: unknown) underwent twenty minute excursion of 0.8c with no reported adverse event (product storage error) (unknown latency).  On an unknown date, 2 patients who were administered poliomyelitis vaccine (inactivated) (unknown dose and route) in unknown administration site for Immunization post temperature excursion with no reported adverse event (poor quality product administered) (latency: same day).  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Began as moderate pain in rear chest/spine days after the vaccine.  Began experience numbness and tingling/burning pain in hands and feet.  Increase in heartrate and bloodpressure.  Numbness and tingling went further up into legs and forearms, mostly symmetric.  Swelling and redness in joints.  Some flushing of face (cheeks).  Electric shooting pains, and some muscle tremors (mostly hands). By 7th day pain was extreme and I had trouble walking, left foot was barely working (dragging).  Fatigue. Had trouble urinating and defecating (muscles were not responding normally).  Sought medical care at urgent care, was given xray; other than some inflammation was inconclusive. Given steroids and skeletal muscle relaxer then dismissed.  Began trying desperately to get medical care, was waitlisted or generally rejected becasuse I was seeking help for vaccine injury.  Continued to have intense flare ups of these symptoms for months. Eventually began a downward trend in frequency and intensity, but my baseline is still experiencing symptoms, fatigue, joint pain and strong paraesthesia which dramatically reduced quality of life.  I have also had lingering tightness and pain in chest, including a hospitalization for a flare up of this.
hospitalized 8/23 throu 8/27 for unknown reason. case not interviewed.
Pt developed large area of redness L proximal deltoid area at site of injection (7x10 cm).  Temp 99.5.  Treated with cephalexin 500mg TID x7 d.